User: prashantiyengar Topic: IP
Category: patents :: india
Last updated: Aug 21 2016 19:25 IST RSS 2.0
 
1 to 20 of 5,825    
Swamy attacks CEA Arvind Subramanian again 21.8.2016 TOI: Home
Swamy had in late June trained his guns on Arvind Subramanian and demanded his sacking for allegedly taking anti-India stance when he was an IMF economist at Washington prior to joining the Finance Ministry. Arun Jaitley had debunked Swamy's call saying "Government has full confidence in CEA."
Also found in: [+]
Central database on encumbrances coming soon 19.8.2016 ET: Policy
Banks, financial institutions, asset reconstruction companies and debenture trustees will get priority over any other arrears including taxation dues of central or state governments.
Also found in: [+]
Global Innovation Index: India moves up to 66th rank this year 17.8.2016 ET: Indicators
The report said India was starting to excel in ICT and creative goods exports, setting a good example of how policy was improving the innovation environment.
Also found in: [+]
Orkut, once India's social media darling, is back 15.8.2016 ET: Infotech
When Google finally shut it down in September 2014, the internet saw nostalgic tributes. For many, Orkut was their introduction to social networking.
Also found in: [+]
​ Pfizer plans to bring more global drugs to India 15.8.2016 ET: Pharma
Although the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which have expired, to the domestic market.
Also found in: [+]
Expanding markets, launching new products for growth: Wockhardt 14.8.2016 ET: Pharma
In the last 10 years, global research in antibiotics has declined and the number of patents filed globally has gone down by 60 per cent.
Also found in: [+]
Workhardt to expand markets, launch new products for growth 14.8.2016 DNA: Top News
Pharma major Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth. "We have always believed that R&D is the key to the future. Naturally, we continue to increase our industry- leading investment in R&D as a percentage of total sales every year," Wockhardt Chairman and group CEO Habil Khorakiwala said at the company's annual general meeting (AGM). In the April - June quarter, Wockhardt's net profit plunged 83% to Rs 16 crore on the back of a dip in sales and increased expenditure, the company said.  "In FY16, our R&D spend of Rs 669 crore at 15% of total sales is almost 30% higher than our investment in R&D of Rs 515 crore at 11.5% of total sales in FY 15," he said. The company has various drugs at different stages of development, he said, adding: "We expect that in the next 3 to 5 years, we will have launched some of these drugs in Indian and global markets. Collectively, we are serving diverse patients with unmet needs ...
Also found in: [+]
LeEco CEO Jia Yueting becomes chairman of major smartphone maker Coolpad 9.8.2016 Sify Finance
Internet and technology conglomerate LeEco announced that its Founder, Chairman and Chief Executive Officer Jia Yueting has become the Chairman of the Board and the Nominating Committee of the
Also found in: [+]
MSF and Pfizer battle over patent application for life-saving pneumonia vaccine 29.7.2016 ET: Pharma
MSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious and predictable.
Also found in: [+]
Commerce Minister Smt. Nirmala Sitharaman says Government will hold to have all stakeholders of the Startup ecosystem on board in making India one of the best Startup destinations in the world. 28.7.2016 Govt of india: PIB
The Startup India initiative is designed to foster innovation, create jobs and facilitate investment. Government is committed to make this initiative a scalable reality and to provide an environment for our Startups to thrive in.
Also found in: [+]
Startup India: Why the progress is in slow lane 28.7.2016 Rediff: Top Stories (India)
Seven months down the line, not much progress has been made.
Also found in: [+]
Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brands 27.7.2016 ET: Pharma
The acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.
Also found in: [+]
India rejects 955 pharma patent applications in last three years 25.7.2016 ET: Pharma
To a separate query, she said India is considered as a leading exporter and holds second position in export of generic drugs in terms of volumes.
Also found in: [+]
Emphasis on research, cloud to herald digital transformation in India: Adobe 25.7.2016 ET: Software
Adobe India continues to see major growth and India is, in fact, one of the most strategic markets for the company globally.
Also found in: [+]
Red tape snipped for start-ups 24.7.2016 Rediff: Top Stories (India)
Vetting by inter-ministerial board removed for benefits under Startup India Action Plan
Also found in: [+]
MSF urges India to continue pushing generic drugs 21.7.2016 DNA: Urban Tales
In a report presented on HIV drug pricing released at a conference in Durban on Thursday, the international medical humanitarian organisation Médecins Sans Frontières (MSF), also known as Doctors Without Borders, stressed on the need for India to encourage generic drugs. "India is under massive pressure to turn off its tap of affordable medicines, which are lifeline for millions of people not only in India, but across the developing world," said Leena Menghaney, South Asia Head of MSF's Access Campaign. "If India doesn't stand strong against pharmaceutical corporations and governments that are pushing for change in the country's patent law and policies, people around the world will face a crisis in access to medicines in the future," she said. While the prices of drugs of the first line and second line treatment have continued to fall, third line treatment remains expensive. The third line drugs are needed by people who have become resistant to other drugs. Cost of third line treatment for HIV can go up ...
Also found in: [+]
Made-in India! Altigreen's engine to increase mileage, cut pollution 20.7.2016 Rediff: Top Stories (India)
Altigreen's hybrid engine will help make cars more fuel efficient and the air we breathe cleaner.
Also found in: [+]
Granules to acquire 12.5 per cent stake in USpharma 14.7.2016 ET: Pharma
USpharma is a development-stage pharmaceutical company specialising in research, development and manufacture of high entry-barrier generic pharmaceuticals.
Also found in: [+]
Protection of IPR a must, says expert 12.7.2016 The Assam Tribune
Protection of IPR a must, says expert
Also found in: [+]
India should reject efforts weakening access to generic drugs 7.7.2016 ET: Pharma
MSF urged Modi to defend India's lifeline to South Africa and developing countries through affordable versions of new medicines.
Also found in: [+]
1 to 20 of 5,825